The model homologue of the partially defective human 5,10-methylenetetrahydrofolate reductase, considered as a risk factor for stroke due to increased homocysteine level, can be protected and reactivated by heat shock proteins by Grabowski, Michał et al.
The model homologue of the partially defective human 5,10-methylenetetrahydrofolate reductase, considered as a risk factor for stroke due to increased homocysteine level, can be protected and reactivated by heat shock proteins


Michał Grabowskia, Bogdan Baneckia, Leszek Kadzińskia, Joanna Jakóbkiewicz-Baneckab, Magdalena Gabig-Cimińskac, Alicja Węgrzync, Grzegorz Węgrzynb, Zyta
Banecka-Majkutewiczd,*

a Intercollegiate Faculty of Biotechnology, University of Gdańsk and Medical University of
10 Gdańsk, Kładki 24, 80-822 Gdańsk, Poland
b Department of Molecular Biology, University of Gdańsk, Wita Stwosza 59, 80-308 Gdańsk, Poland
c Laboratory of Molecular Biology (affiliated with the University of Gdańsk), Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Wita Stwosza 59, 80-308 Gdańsk,
Poland








The A222V substitution in the human MTHFR gene product (5,10-methylenetetrahydrofolate reductase) is responsible for a decreased activity of this enzyme. This may cause an increased homocysteine level, considered as a risk factor for arteriosclerosis and stroke. The bacterial homologue of the human enzyme, MetF, has been found to be a useful model in genetic and biochemical studies. The similarity of Escherichia coli MetF and human MTHFR proteins is so high that particular mutations in the corresponding human gene can be reflected by the bacterial mutants. For example, the A222V substitution in MTHFR (caused by the C667T substitution in the MTHFR gene) can be ascribed to the A117V substitution in MetF. Here, it is reported that a temperature-sensitive MetF117 (A117V) protein can be partially protected from a thermal inactivation by the heat shock proteins from the Hsp70/100 systems. Moreover, activity of the thermally denatured enzyme can be partially restored by the same heat shock proteins. High temperature protein G (HtpG) had no effect on MetF117 activity in both experimental systems. The presented results indicate that functions of heat shock proteins may be required for maintenance of the MetF117 function. This may have implications for the mechanisms of arteriosclerosis and stroke, especially in the light of previous findings that the A222V MTHFR polymorphism may be a risk factor for stroke, as well as recently published results which demonstrated the increased levels of antibodies against heat shock proteins in stroke patients. 






5,10-Methylenetetrahydrofolate reductase (EC 1.5.1.20) is encoded in humans by the MTHFR gene. This enzyme is involved in homocysteine metabolism (presented schematically in Fig. 1), as it catalyses the conversion of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, which serves as a methyl donor in the remethylation of homocysteine to methionine (Bailey and Gregory III 1999). Therefore, dysfunction or decreased activity of the MTHFR gene product leads to increased levels of homocysteine. Hyperhomocysteinemia causes toxicity to vascular and nervous systems (Perła-Kaján et al. 2007). Thus, this metabolic defect is considered a risk factor for various diseases, including stroke, minimal cognitive impairment, dementia, Parkinson disease, multiple sclerosis, epilepsy, and eclampsia (for reviews see Ansari et al. 2014; Keshteli et al. 2015).
Among diseases for which hyperhomocysteinemia is a risk factor, stroke is one of the most severe disorders (for a review, see Banecka-Majkutewicz et al. 2012). Increased levels of homocysteine was correlated with the incidence of stroke in as various populations as those from Poland (Sawuła et al. 2009) and Karachi (Sadiq et al. 2014). Recent studies indicated that in stroke patients there are increased levels of antibodies against heat shock proteins (Hsps) (Banecka-Majkutewicz et al. 2014). Such results might suggest an essential role for Hsp deficiency in development of the atherosclerosis and stroke. However, the exact
role of Hsps in putative stroke prevention remains unclear. Some light on this problem was shed by studies demonstrating that the Hsp70/100 system has a role in maintaining activity of Escherichia coli MetH protein, a homologue of human methionine synthase, another enzyme involved in homocysteine metabolism (Grabowski et al. 2012). Since there is a high similarity between E. coli MetH and human methionine synthase, one might suggest that increased levels of anti-Hsps antibodies might reduce the efficiency of the chaperone systems, thus interfering with the homocysteine metabolism. 
	Continuing this line of studies, we aimed to investigate a potential role for Hsps in modulation of activity of the E. coli MetF protein, a homologue of the human 5,10-methylenetetrahydrofolate reductase (MTHFR). The level of similarity between these enzymes is so high that particular amino acid residues in MetF can be ascribed to their counterparts is MTHFR. For example A222 in MTHFR corresponds to A117 in MetF (Guenther et al. 1999). On the basis of structural and biochemical properties of the mutated





Overproduction of proteins was performed in E. coli BL21(DE3) RIL in TB medium with 5 M FAD. The wild-type MetF protein was purified as described previously (Shepard et al. 1999). The 117 variant of MetF was purified analogously as the wild-type enzyme, but all buffers used for purification of MetF117 were supplemented with 5 M FAD. 
DnaK, GrpE, DnaJ, ClpB and HtpG were overproduced and purified according to the previously published methods (Banecki and Żylicz 1996; Banecki et al. 1996; Spence and Georgopoulos 1989; Woo et al., 1992; Wawrzynów et al., 1995).

Determination of methylenetetrahydrofolate reductase activity
Activity of methylenetetrahydrofolate reductase was performed as described previously (Shepard et al. 1999), by measuring a decrease in absorbance of NADH, consumed during the reaction. The reaction mixture consisted of 50 mM phosphate buffer containing 10% glycerol, 0.3 mM EDTA, 400 M NADH, and 1.4 mM menadione (vitamin K3 is used as an artificial substrate for MetF). The activity of MetF was determined by measurement of the kinetics of the reaction at 37oC. The reaction mixture was prepared without the enzyme, and incubated for 5 min. Following reaction initiation by the addition of 0.3 M enzyme, the measurement was carried out for 30 min, by monitoring the absorbance at a wavelength of 340 nm. 

Protection of MetF117 from temperature-mediated denaturation by Hsps
MetF (at final concentration of 0.3 µM) was pre-incubated in the presence of 50 mM phosphate buffer (pH 7.2) containing 10% glycerol, 0.3 mM EDTA, 50 mM NaCl, 20 mM KCl, 20 mM MgCl2, and in the presence of DnaK, DnaJ, GrpE, ClpB (the Hsp 70/100 system) or HtpG, and 5 mM ATP. The concentrations of heat shock proteins were 3.7 µM, 1.4 µM, 0.36 µM, 1.5 µM, respectively for Hsp70/100, and 3.6 µM for HtpG. The incubation was carried out for 15 min at 50oC. Finally, the samples were subjected to the MetF activity test.

Reactivation of thermally-denatured MetF117 by Hsps




Wild-type and the 117V variant of E. coli methylenetetrahydrofolate reductase, MetF and MetF117, respectively, were purified from bacteria overexpressing corresponding metF alleles from a plasmid. We found that both variants of the enzyme had similar activities at 37oC (Fig. 2A). 
To test effects of an increased temperature on MetF activity, the reaction mixtures were incubated at various temperatures. Significantly higher thermosensitivity of MetF117, relative to the wild-type enzyme, was observed (Fig. 2B). For further experiments, temperature 50oC was chosen, at which the difference between both variants of the enzyme was the most pronounced.
We found that the proteins from the Hsp70/100 system, DnaK, DnaJ, GroEL, ClpB, could partially protect the MetF117 protein against thermal denaturation (Fig. 3A). The mutated enzyme revealed a significantly higher activity at 50oC in the presence of the Hps70/100  systems than in the absence of Hsps. HtpG had no significant effect on MetF117 activity.  




The results presented in this report indicate that Hsps have important roles in activation of the mutated MetF variant. The in vitro experiments were performed at 50oC to demonstrate the most pronounced effects which occurred at an extremely high temperature relative to physiological conditions. However, most probably, similar functions of the Hsp70/100 system may be important at physiological temperatures in living organisms. 
Because of the high similarity, both structural (Guenther et al. 1999) and functional (Jakóbkiewicz-Banecka et al. 2005), between bacterial MetF and human MTHFR proteins, and their thermosensitive variants 117V and 222V, respectively, we suggest that some implications can be proposed for the human organism. The 667T allele of the MTHFR gene has been shown to cause a decreased activity of the encoded enzyme, and an increased levels of homocysteine, even if occurring in the heterogyzotic state (Kluijtmans and Whitehead 2001). Moreover, hyperhomocysteinemia was considered as a risk factor for stroke (Sawuła et al. 2009; Ansari et al. 2014; Sadiq et al. 2014). Nevertheless, it is obvious that not all persons having an increased plasma level of homocysteine suffer from stroke. Therefore, other factors,  agents and/or conditions must also be involved in the mechanism of an increased risk of this disorder in persons with hyperhomocysteinemia. One of them may be Hsps, as these proteins can modulate activity of methylenetetrahydrofolate reductase, and particularly its thermolabille form. 
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